TPD A Rising Option For Korean Pharma Seeking New Modalities
SK Biopharm Making Aggressive Move
Highlighted by SK Biopharmaceuticals’ recent decision to acquire the US-based ProteoVant Sciences, Korean pharma firms are stepping up deals and collaborations in the hot TPD space, which is expected to continue to attract global investors and big pharma interest.
